TY - JOUR
T1 - Lifetime bipolar disorder comorbidity and related clinical characteristics in patients with primary obsessive compulsive disorder
T2 - A report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)
AU - Dell'osso, Bernardo
AU - Vismara, Matteo
AU - Benatti, Beatrice
AU - Cirnigliaro, Giovanna
AU - Grancini, Benedetta
AU - Fineberg, Naomi A.
AU - Van Ameringen, Michael
AU - Hollander, Eric
AU - Stein, Dan J.
AU - Menchon, Josè M.
AU - Rodriguez, Carolyn I.
AU - Nicolini, Humberto
AU - Lanzagorta, Nuria
AU - Pallanti, Stefano
AU - Grassi, Giacomo
AU - Lochner, Christine
AU - Marazziti, Donatella
AU - Hranov, Georgi
AU - Karamustafalioglu, Oguz
AU - Hranov, Luchezar
AU - Zohar, Joseph
N1 - Funding Information:
N. Fineberg reports personal fees from Otsuka, personal fees from Lundbeck, nonfinancial support from Janssen, grants and nonfinancial support from the ECNP, personal fees and nonfinancial support from BAP, nonfinancial support from the World Health Organization, personal fees and nonfinancial support from RANZCP, grants and nonfinancial support from Shire, grants from the National Institute of Health Research, personal fees and nonfinancial support from the College of Mental Health Pharmacists, nonfinancial support from the International Society of Behavioural Addiction, nonfinancial support from the Royal College of Psychiatrists, nonfinancial support from the International College of Obsessive–Compulsive Spectrum Disorders, nonfinancial support from Novartis, grants and nonfinancial support from Servier, personal fees from Bristol-Myers Squibb, grants from MRC, grants from Wellcome, personal fees from Taylor and Francis, and personal fees from Oxford University Press, outside the submitted work.
Funding Information:
E. Hollander reports grants from Brainsway, grants from Roche, grants from Curemark, grants from Takeda, personal fees from Shire, and personal fees from Sunovion, outside the submitted work. D.J. Stein reports personal fees from Lundbeck, personal fees from Novartis, personal fees from the AMBRF, grants from the NRGF, grants from Servier, grants from Biocodex, grants from MRC, personal fees from CIPLA Inc., and personal fees from SUN, outside the submitted work.
Publisher Copyright:
© Cambridge University Press 2019.
PY - 2020/6/1
Y1 - 2020/6/1
N2 - Introduction. Bipolar disorder (BD) and obsessive compulsive disorder (OCD) are prevalent, comorbid, and disabling conditions, often characterized by early onset and chronic course. When comorbid, OCD and BD can determine a more pernicious course of illness, posing therapeutic challenges for clinicians. Available reports on prevalence and clinical characteristics of comorbidity between BD and OCD showed mixed results, likely depending on the primary diagnosis of analyzed samples.Methods. We assessed prevalence and clinical characteristics of BD comorbidity in a large international sample of patients with primary OCD (n = 401), through the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) snapshot database, by comparing OCD subjects with vs without BD comorbidity.Results. Among primary OCD patients, 6.2% showed comorbidity with BD. OCD patients with vs without BD comorbidity more frequently had a previous hospitalization (p < 0.001) and current augmentation therapies (p < 0.001). They also showed greater severity of OCD (p < 0.001), as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).Conclusion. These findings from a large international sample indicate that approximately 1 out of 16 patients with primary OCD may additionally have BD comorbidity along with other specific clinical characteristics, including more frequent previous hospitalizations, more complex therapeutic regimens, and a greater severity of OCD. Prospective international studies are needed to confirm our findings.
AB - Introduction. Bipolar disorder (BD) and obsessive compulsive disorder (OCD) are prevalent, comorbid, and disabling conditions, often characterized by early onset and chronic course. When comorbid, OCD and BD can determine a more pernicious course of illness, posing therapeutic challenges for clinicians. Available reports on prevalence and clinical characteristics of comorbidity between BD and OCD showed mixed results, likely depending on the primary diagnosis of analyzed samples.Methods. We assessed prevalence and clinical characteristics of BD comorbidity in a large international sample of patients with primary OCD (n = 401), through the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) snapshot database, by comparing OCD subjects with vs without BD comorbidity.Results. Among primary OCD patients, 6.2% showed comorbidity with BD. OCD patients with vs without BD comorbidity more frequently had a previous hospitalization (p < 0.001) and current augmentation therapies (p < 0.001). They also showed greater severity of OCD (p < 0.001), as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS).Conclusion. These findings from a large international sample indicate that approximately 1 out of 16 patients with primary OCD may additionally have BD comorbidity along with other specific clinical characteristics, including more frequent previous hospitalizations, more complex therapeutic regimens, and a greater severity of OCD. Prospective international studies are needed to confirm our findings.
KW - Bipolar disorder
KW - comorbidity
KW - obsessive compulsive disorder
KW - prevalence
UR - http://www.scopus.com/inward/record.url?scp=85066908255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066908255&partnerID=8YFLogxK
U2 - 10.1017/S1092852919001068
DO - 10.1017/S1092852919001068
M3 - Article
C2 - 31131775
AN - SCOPUS:85066908255
SN - 1092-8529
VL - 25
SP - 419
EP - 425
JO - CNS Spectrums
JF - CNS Spectrums
IS - 3
ER -